Management of hemorrhagic complications associated with percutaneous nephrolithotomy

Journal of Endourology

Volumn 23, Issue 10, 2009, Pages 1763-1767

  Rastinehad, Ardeshir R ^a   Andonian, Sero ^a   Smith, Arthur D ^a   Siegel, David N ^b  

^a The Arthur Smith Institute for Urology   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; ASCORBIC ACID; CLOPIDOGREL; HEPARIN; IOHEXOL; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ANTICOAGULANT THERAPY; ARTERIOVENOUS FISTULA; ARTERY OCCLUSION; ARTIFICIAL EMBOLISM; BLOOD CLOTTING; BLOOD TRANSFUSION; CATHETER; CATHETERIZATION; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTRAST MEDIUM EXTRAVASATION; CRYSTALLOID; DIGITAL SUBTRACTION ANGIOGRAPHY; DISEASE ASSOCIATION; DRUG MEGADOSE; EXTRACORPOREAL LITHOTRIPSY; FALSE ANEURYSM; GOLD STANDARD; GUIDE WIRE; HEMATOMA; HIGH RISK PATIENT; HUMAN; HYDRATION; INCIDENCE; INVASIVE PROCEDURE; KIDNEY ANGIOGRAPHY; KIDNEY ARTERY STENOSIS; KIDNEY FAILURE; KIDNEY HEMORRHAGE; MINIMALLY INVASIVE PROCEDURE; MINIMALLY INVASIVE SURGERY; NEEDLE; NEPHROLITHIASIS; NEPHROLITHOTOMY; PERCUTANEOUS NEPHROLITHOTOMY; PERIRENAL HEMATOMA; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RENAL PROTECTION; REVIEW; RISK FACTOR; SURGICAL EQUIPMENT; THROMBOEMBOLISM; UTERINE CERVIX CARCINOMA IN SITU;

EMBOLIZATION, THERAPEUTIC; HUMANS; NEPHROSTOMY, PERCUTANEOUS; POSTOPERATIVE HEMORRHAGE;

EID: 70350736600     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2009.1548     Document Type: Review

References (22)

1. White EC, Smith AD. Percutaneous stone extraction from 200 patients. J Urol 1984;132:437-438.
2. Shah O, Assimos DG. Complications of percutaneous renal surgery. In: Smith AD, Badlani G, Bagley D, et al, eds. Smith's Textbook of Endourology. 2nd ed. Hamilton, Ontario: BC Decker, 2007, pp 159-164.
3. Lang EK. Percutaneous nephrostolithotomy and lithotripsy: A multi-institutional survey of complications. Radiology 1987;162:25-30.
4. Duvdevani M, Razvi H, Sofer M, et al. Third Prize: Contemporary percutaneous nephrolithotripsy: 1585 procedures in 1338 consecutive patients. J Endourol 2007;21:824-829.
5. Fleisher LA, Beckman JA, Brown KA, et al. ACC=AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: Executive summary: A report of the American College of Cardiology American Heart Association Task Force on Practice Guidelines. Anesth Analg 2008;106:685-712.
6. Kefer JC, Turna B, Stein RJ, Desai MM. Safety and efficacy of percutaneous nephrostolithotomy in patients on anticoagulant therapy. J Urol 2009;181:144-148.
7. Lee WJ, Smith AD, Cubelli V, et al. Complications of percutaneous nephrolithotomy. AJR Am J Roentgenol 1987;148: 177-180.
8. Stoller ML, Wolf JS Jr, St Lezin MA. Estimated blood loss and transfusion rates associated with percutaneous nephrolithotomy. J Urol 1994;152:1977-1981.
9. Srivastava A, Singh KJ, Suri A, et al. Vascular complications after percutaneous nephrolithotomy: Are there any predictive factors? Urology 2005;66:38-40.
10. Gupta M, Bellman GC, Smith AD. Massive hemorrhage from renal vein injury during percutaneous renal surgery: Endourological management. J Urol 1997;157:795-797.
11. KayeKW,Clayman RV. Tamponade nephrostomy catheter for percutaneous nephrostolithotomy. Urology 1986;27:441-445.
12. Kerbl K, Picus DD, Clayman RV. Clinical experience with the Kaye nephrostomy tamponade catheter. Eur Urol 1994; 25:94-98.
13. Bookstein JJ, Ernst CB. Vasodilatory and vasoconstrictive pharmacoangiographic manipulation of renal collateral flow. Radiology 1973;108:55-59.
14. Kessaris DN, Bellman GC, Pardalidis NP, Smith AG. Management of hemorrhage after percutaneous renal surgery. J Urol 1995;153:604-608.
15. Richstone L, Reggio E, Ost MC, et al. First prize (tie): Hemorrhage following percutaneous renal surgery: Characterization of angiographic findings. J Endourol 2008;22:1129-1135.
16. Breyer BN, McAninch JW, Elliott SP, Master VA. Minimally invasive endovascular techniques to treat acute renal hemorrhage. J Urol 2008;179:2248-2253.
17. Andonian S, Atalla MA. Radiation safety in urology. AUA Update Series Lesson 26. 2009;XXVIII:237-247.
18. Hessel SJ, Adams DF, Abrams HL. Complications of angiography. Radiology 1981;138:273-281.
19. Schwartz MJ, Smith EB, Trost DW, Vaughan ED Jr. Renal artery embolization: Clinical indications and experience from over 100 cases. BJU Int 2007;99:881-886.
20. Lufft V, Hoogestraat-Lufft L, Fels LM, et al. Contrast media nephropathy: Intravenous CT angiography versus intraarterial digital subtraction angiography in renal artery stenosis: A prospective randomized trial. Am J Kidney Dis 2002;40:236-242.
21. Liss P, Eklöf H, Hellberg O, et al. Renal effects of CO2 and iodinated contrast media in patients undergoing renovascular intervention: A prospective, randomized study. J Vasc Interv Radiol 2005;16:57-65.
22. Jo SH, Koo BK, Park JS, et al. N-acetylcysteine versus AScorbic acid for preventing contrast-induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-A prospective randomized controlled trial. Am Heart J 2009;157:576-583.